nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—osteoarthritis—Prednisone—Crohn's disease	0.35	1	CpDpCtD
Sulindac—PTGS2—Crohn's disease	0.114	0.529	CbGaD
Sulindac—ALB—Crohn's disease	0.102	0.471	CbGaD
Sulindac—PTGS2—Balsalazide—Crohn's disease	0.0671	0.229	CbGbCtD
Sulindac—PTGS1—Balsalazide—Crohn's disease	0.0566	0.193	CbGbCtD
Sulindac—PTGS2—Mesalazine—Crohn's disease	0.0536	0.183	CbGbCtD
Sulindac—PTGS1—Mesalazine—Crohn's disease	0.0453	0.155	CbGbCtD
Sulindac—PTGS2—Sulfasalazine—Crohn's disease	0.03	0.102	CbGbCtD
Sulindac—PTGS1—Sulfasalazine—Crohn's disease	0.0253	0.0864	CbGbCtD
Sulindac—ALB—Prednisone—Crohn's disease	0.0151	0.0516	CbGbCtD
Sulindac—MAPK3—mouth—Crohn's disease	0.00198	0.072	CbGeAlD
Sulindac—Urine color abnormal—Mesalazine—Crohn's disease	0.00163	0.0376	CcSEcCtD
Sulindac—AKR1B1—epithelium—Crohn's disease	0.00159	0.0578	CbGeAlD
Sulindac—AKR1B1—smooth muscle tissue—Crohn's disease	0.00153	0.0557	CbGeAlD
Sulindac—AKR1B1—mammalian vulva—Crohn's disease	0.00138	0.0501	CbGeAlD
Sulindac—AKR1B1—lymphoid tissue—Crohn's disease	0.00122	0.0445	CbGeAlD
Sulindac—AKR1B1—digestive system—Crohn's disease	0.00121	0.044	CbGeAlD
Sulindac—MAPK3—epithelium—Crohn's disease	0.00115	0.0419	CbGeAlD
Sulindac—MAPK3—smooth muscle tissue—Crohn's disease	0.00111	0.0404	CbGeAlD
Sulindac—MAPK3—skin of body—Crohn's disease	0.00109	0.0398	CbGeAlD
Sulindac—PPARD—mammalian vulva—Crohn's disease	0.00108	0.0394	CbGeAlD
Sulindac—Chromaturia—Mesalazine—Crohn's disease	0.00107	0.0248	CcSEcCtD
Sulindac—ALB—gall bladder—Crohn's disease	0.00106	0.0386	CbGeAlD
Sulindac—Bone marrow depression—Mercaptopurine—Crohn's disease	0.00105	0.0241	CcSEcCtD
Sulindac—MAPK3—mammalian vulva—Crohn's disease	0.000999	0.0363	CbGeAlD
Sulindac—PPARD—lymphoid tissue—Crohn's disease	0.000962	0.035	CbGeAlD
Sulindac—PPARD—digestive system—Crohn's disease	0.00095	0.0346	CbGeAlD
Sulindac—Cholestasis—Mercaptopurine—Crohn's disease	0.00093	0.0215	CcSEcCtD
Sulindac—MAPK3—lymphoid tissue—Crohn's disease	0.000887	0.0323	CbGeAlD
Sulindac—MAPK3—digestive system—Crohn's disease	0.000876	0.0319	CbGeAlD
Sulindac—Nephrotic syndrome—Mesalazine—Crohn's disease	0.000793	0.0183	CcSEcCtD
Sulindac—AKR1B1—lymph node—Crohn's disease	0.00069	0.0251	CbGeAlD
Sulindac—Cholecystitis—Mesalazine—Crohn's disease	0.000667	0.0154	CcSEcCtD
Sulindac—Bone marrow depression—Azathioprine—Crohn's disease	0.000623	0.0144	CcSEcCtD
Sulindac—Cholelithiasis—Mesalazine—Crohn's disease	0.000616	0.0142	CcSEcCtD
Sulindac—CYP1A1—mouth—Crohn's disease	0.000612	0.0223	CbGeAlD
Sulindac—PTGS2—gall bladder—Crohn's disease	0.000578	0.021	CbGeAlD
Sulindac—Nephritis interstitial—Mesalazine—Crohn's disease	0.000568	0.0131	CcSEcCtD
Sulindac—Bone marrow depression—Mesalazine—Crohn's disease	0.000568	0.0131	CcSEcCtD
Sulindac—Cholestasis—Azathioprine—Crohn's disease	0.000554	0.0128	CcSEcCtD
Sulindac—PPARD—lymph node—Crohn's disease	0.000543	0.0198	CbGeAlD
Sulindac—PTGS2—mouth—Crohn's disease	0.000514	0.0187	CbGeAlD
Sulindac—Cholestasis—Mesalazine—Crohn's disease	0.000505	0.0117	CcSEcCtD
Sulindac—Pleural effusion—Mesalazine—Crohn's disease	0.0005	0.0116	CcSEcCtD
Sulindac—Tubulointerstitial nephritis—Mesalazine—Crohn's disease	0.0005	0.0116	CcSEcCtD
Sulindac—MAPK3—lymph node—Crohn's disease	0.0005	0.0182	CbGeAlD
Sulindac—Tenderness—Mesalazine—Crohn's disease	0.000439	0.0101	CcSEcCtD
Sulindac—Proteinuria—Mesalazine—Crohn's disease	0.000436	0.0101	CcSEcCtD
Sulindac—Pancreatitis—Mercaptopurine—Crohn's disease	0.000434	0.01	CcSEcCtD
Sulindac—Protein urine present—Mesalazine—Crohn's disease	0.00043	0.00993	CcSEcCtD
Sulindac—Pancytopenia—Mercaptopurine—Crohn's disease	0.000421	0.00971	CcSEcCtD
Sulindac—Leukocytosis—Mesalazine—Crohn's disease	0.000408	0.00941	CcSEcCtD
Sulindac—Colitis—Azathioprine—Crohn's disease	0.000404	0.00933	CcSEcCtD
Sulindac—Aplastic anaemia—Azathioprine—Crohn's disease	0.000395	0.00912	CcSEcCtD
Sulindac—Stomatitis—Mercaptopurine—Crohn's disease	0.000385	0.00889	CcSEcCtD
Sulindac—Colitis—Mesalazine—Crohn's disease	0.000368	0.0085	CcSEcCtD
Sulindac—Aplastic anaemia—Mesalazine—Crohn's disease	0.00036	0.00831	CcSEcCtD
Sulindac—CYP1A1—epithelium—Crohn's disease	0.000356	0.013	CbGeAlD
Sulindac—Coma—Mesalazine—Crohn's disease	0.00035	0.00808	CcSEcCtD
Sulindac—Ecchymosis—Mesalazine—Crohn's disease	0.000346	0.008	CcSEcCtD
Sulindac—Hepatic failure—Azathioprine—Crohn's disease	0.00034	0.00785	CcSEcCtD
Sulindac—CYP1A1—skin of body—Crohn's disease	0.000339	0.0123	CbGeAlD
Sulindac—Photosensitivity—Mesalazine—Crohn's disease	0.000317	0.00731	CcSEcCtD
Sulindac—Gastroenteritis—Mesalazine—Crohn's disease	0.000314	0.00725	CcSEcCtD
Sulindac—Alopecia—Mercaptopurine—Crohn's disease	0.000313	0.00723	CcSEcCtD
Sulindac—PTGS1—epithelium—Crohn's disease	0.000313	0.0114	CbGeAlD
Sulindac—Hepatic failure—Mesalazine—Crohn's disease	0.00031	0.00715	CcSEcCtD
Sulindac—CYP1A1—mammalian vulva—Crohn's disease	0.000309	0.0112	CbGeAlD
Sulindac—Peptic ulcer—Prednisone—Crohn's disease	0.000303	0.007	CcSEcCtD
Sulindac—PTGS1—smooth muscle tissue—Crohn's disease	0.000301	0.011	CbGeAlD
Sulindac—PTGS2—epithelium—Crohn's disease	0.000299	0.0109	CbGeAlD
Sulindac—PTGS1—skin of body—Crohn's disease	0.000298	0.0108	CbGeAlD
Sulindac—Renal impairment—Mesalazine—Crohn's disease	0.000292	0.00675	CcSEcCtD
Sulindac—PTGS2—smooth muscle tissue—Crohn's disease	0.000288	0.0105	CbGeAlD
Sulindac—Arthritis—Mesalazine—Crohn's disease	0.000286	0.00661	CcSEcCtD
Sulindac—Anaemia—Mercaptopurine—Crohn's disease	0.000285	0.00659	CcSEcCtD
Sulindac—PTGS2—skin of body—Crohn's disease	0.000284	0.0104	CbGeAlD
Sulindac—Gastrointestinal haemorrhage—Mesalazine—Crohn's disease	0.000278	0.00642	CcSEcCtD
Sulindac—Leukopenia—Mercaptopurine—Crohn's disease	0.000276	0.00638	CcSEcCtD
Sulindac—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.000275	0.00635	CcSEcCtD
Sulindac—CYP1A2—digestive system—Crohn's disease	0.000275	0.01	CbGeAlD
Sulindac—Neuritis—Prednisone—Crohn's disease	0.000272	0.00627	CcSEcCtD
Sulindac—PTGS1—mammalian vulva—Crohn's disease	0.000271	0.00988	CbGeAlD
Sulindac—CYP1A1—digestive system—Crohn's disease	0.000271	0.00986	CbGeAlD
Sulindac—Arthralgia—Mercaptopurine—Crohn's disease	0.000263	0.00607	CcSEcCtD
Sulindac—Pancreatitis—Azathioprine—Crohn's disease	0.000259	0.00597	CcSEcCtD
Sulindac—Oedema—Mercaptopurine—Crohn's disease	0.000252	0.00582	CcSEcCtD
Sulindac—Pancytopenia—Azathioprine—Crohn's disease	0.000251	0.00579	CcSEcCtD
Sulindac—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000247	0.00569	CcSEcCtD
Sulindac—Gastritis—Mesalazine—Crohn's disease	0.000246	0.00568	CcSEcCtD
Sulindac—Anorexia—Mercaptopurine—Crohn's disease	0.00024	0.00554	CcSEcCtD
Sulindac—ALB—lymph node—Crohn's disease	0.000239	0.00868	CbGeAlD
Sulindac—Eosinophilia—Mesalazine—Crohn's disease	0.000238	0.0055	CcSEcCtD
Sulindac—PTGS1—digestive system—Crohn's disease	0.000238	0.00866	CbGeAlD
Sulindac—Pneumonia—Azathioprine—Crohn's disease	0.000237	0.00547	CcSEcCtD
Sulindac—Bronchospasm—Mesalazine—Crohn's disease	0.000236	0.00546	CcSEcCtD
Sulindac—Pancreatitis—Mesalazine—Crohn's disease	0.000236	0.00544	CcSEcCtD
Sulindac—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.000233	0.00539	CcSEcCtD
Sulindac—PTGS2—lymphoid tissue—Crohn's disease	0.00023	0.00838	CbGeAlD
Sulindac—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00023	0.0053	CcSEcCtD
Sulindac—Pancytopenia—Mesalazine—Crohn's disease	0.000228	0.00527	CcSEcCtD
Sulindac—PTGS2—digestive system—Crohn's disease	0.000227	0.00828	CbGeAlD
Sulindac—Dysuria—Mesalazine—Crohn's disease	0.000225	0.00519	CcSEcCtD
Sulindac—Neutropenia—Mesalazine—Crohn's disease	0.000225	0.00519	CcSEcCtD
Sulindac—Agranulocytosis—Azathioprine—Crohn's disease	0.00022	0.00507	CcSEcCtD
Sulindac—Photosensitivity reaction—Mesalazine—Crohn's disease	0.000219	0.00507	CcSEcCtD
Sulindac—Decreased appetite—Mercaptopurine—Crohn's disease	0.000219	0.00506	CcSEcCtD
Sulindac—Leukocytosis—Prednisone—Crohn's disease	0.000216	0.00498	CcSEcCtD
Sulindac—Pneumonia—Mesalazine—Crohn's disease	0.000216	0.00498	CcSEcCtD
Sulindac—Depression—Mesalazine—Crohn's disease	0.000214	0.00494	CcSEcCtD
Sulindac—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.000213	0.00491	CcSEcCtD
Sulindac—Renal failure—Mesalazine—Crohn's disease	0.000211	0.00487	CcSEcCtD
Sulindac—Neuropathy peripheral—Mesalazine—Crohn's disease	0.00021	0.00485	CcSEcCtD
Sulindac—Stomatitis—Mesalazine—Crohn's disease	0.000209	0.00482	CcSEcCtD
Sulindac—Jaundice—Mesalazine—Crohn's disease	0.000209	0.00482	CcSEcCtD
Sulindac—Conjunctivitis—Mesalazine—Crohn's disease	0.000208	0.00481	CcSEcCtD
Sulindac—Sweating—Mesalazine—Crohn's disease	0.000206	0.00475	CcSEcCtD
Sulindac—Haematuria—Mesalazine—Crohn's disease	0.000204	0.00472	CcSEcCtD
Sulindac—Epistaxis—Mesalazine—Crohn's disease	0.000202	0.00467	CcSEcCtD
Sulindac—Agranulocytosis—Mesalazine—Crohn's disease	0.0002	0.00462	CcSEcCtD
Sulindac—Erythema multiforme—Azathioprine—Crohn's disease	0.0002	0.00461	CcSEcCtD
Sulindac—Body temperature increased—Mercaptopurine—Crohn's disease	0.000199	0.0046	CcSEcCtD
Sulindac—Hepatitis—Mesalazine—Crohn's disease	0.000192	0.00444	CcSEcCtD
Sulindac—Chills—Azathioprine—Crohn's disease	0.00019	0.00438	CcSEcCtD
Sulindac—Arrhythmia—Azathioprine—Crohn's disease	0.000189	0.00436	CcSEcCtD
Sulindac—Alopecia—Azathioprine—Crohn's disease	0.000187	0.00431	CcSEcCtD
Sulindac—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000186	0.00429	CcSEcCtD
Sulindac—Ecchymosis—Prednisone—Crohn's disease	0.000183	0.00423	CcSEcCtD
Sulindac—Erythema multiforme—Mesalazine—Crohn's disease	0.000182	0.0042	CcSEcCtD
Sulindac—Tinnitus—Mesalazine—Crohn's disease	0.000179	0.00414	CcSEcCtD
Sulindac—Chills—Mesalazine—Crohn's disease	0.000173	0.00399	CcSEcCtD
Sulindac—Diarrhoea—Mercaptopurine—Crohn's disease	0.000172	0.00398	CcSEcCtD
Sulindac—Ill-defined disorder—Azathioprine—Crohn's disease	0.000171	0.00394	CcSEcCtD
Sulindac—Alopecia—Mesalazine—Crohn's disease	0.00017	0.00393	CcSEcCtD
Sulindac—Anaemia—Azathioprine—Crohn's disease	0.00017	0.00392	CcSEcCtD
Sulindac—Malaise—Azathioprine—Crohn's disease	0.000166	0.00383	CcSEcCtD
Sulindac—Flatulence—Mesalazine—Crohn's disease	0.000165	0.00381	CcSEcCtD
Sulindac—Leukopenia—Azathioprine—Crohn's disease	0.000165	0.0038	CcSEcCtD
Sulindac—Vascular purpura—Prednisone—Crohn's disease	0.000165	0.0038	CcSEcCtD
Sulindac—Tension—Mesalazine—Crohn's disease	0.000164	0.0038	CcSEcCtD
Sulindac—Dysgeusia—Mesalazine—Crohn's disease	0.000164	0.00379	CcSEcCtD
Sulindac—Nervousness—Mesalazine—Crohn's disease	0.000163	0.00376	CcSEcCtD
Sulindac—Cardiac failure congestive—Prednisone—Crohn's disease	0.000162	0.00375	CcSEcCtD
Sulindac—Vomiting—Mercaptopurine—Crohn's disease	0.00016	0.0037	CcSEcCtD
Sulindac—Rash—Mercaptopurine—Crohn's disease	0.000159	0.00367	CcSEcCtD
Sulindac—Dermatitis—Mercaptopurine—Crohn's disease	0.000159	0.00366	CcSEcCtD
Sulindac—Vision blurred—Mesalazine—Crohn's disease	0.000158	0.00365	CcSEcCtD
Sulindac—Arthralgia—Azathioprine—Crohn's disease	0.000157	0.00362	CcSEcCtD
Sulindac—Myalgia—Azathioprine—Crohn's disease	0.000157	0.00362	CcSEcCtD
Sulindac—Ill-defined disorder—Mesalazine—Crohn's disease	0.000155	0.00359	CcSEcCtD
Sulindac—Anaemia—Mesalazine—Crohn's disease	0.000155	0.00357	CcSEcCtD
Sulindac—CYP1A1—lymph node—Crohn's disease	0.000155	0.00563	CbGeAlD
Sulindac—Discomfort—Azathioprine—Crohn's disease	0.000155	0.00357	CcSEcCtD
Sulindac—Angioedema—Mesalazine—Crohn's disease	0.000153	0.00353	CcSEcCtD
Sulindac—Purpura—Prednisone—Crohn's disease	0.000153	0.00353	CcSEcCtD
Sulindac—Malaise—Mesalazine—Crohn's disease	0.000151	0.00349	CcSEcCtD
Sulindac—Vertigo—Mesalazine—Crohn's disease	0.000151	0.00348	CcSEcCtD
Sulindac—Syncope—Mesalazine—Crohn's disease	0.00015	0.00347	CcSEcCtD
Sulindac—Leukopenia—Mesalazine—Crohn's disease	0.00015	0.00346	CcSEcCtD
Sulindac—Nausea—Mercaptopurine—Crohn's disease	0.00015	0.00345	CcSEcCtD
Sulindac—Palpitations—Mesalazine—Crohn's disease	0.000148	0.00342	CcSEcCtD
Sulindac—Loss of consciousness—Mesalazine—Crohn's disease	0.000147	0.0034	CcSEcCtD
Sulindac—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.000147	0.0034	CcSEcCtD
Sulindac—Thrombocytopenia—Azathioprine—Crohn's disease	0.000147	0.00339	CcSEcCtD
Sulindac—Hypertension—Mesalazine—Crohn's disease	0.000145	0.00334	CcSEcCtD
Sulindac—Myalgia—Mesalazine—Crohn's disease	0.000143	0.00329	CcSEcCtD
Sulindac—Arthralgia—Mesalazine—Crohn's disease	0.000143	0.00329	CcSEcCtD
Sulindac—Chest pain—Mesalazine—Crohn's disease	0.000143	0.00329	CcSEcCtD
Sulindac—Discomfort—Mesalazine—Crohn's disease	0.000141	0.00325	CcSEcCtD
Sulindac—Hypotension—Azathioprine—Crohn's disease	0.00014	0.00324	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000137	0.00316	CcSEcCtD
Sulindac—Anaphylactic shock—Mesalazine—Crohn's disease	0.000137	0.00316	CcSEcCtD
Sulindac—Oedema—Mesalazine—Crohn's disease	0.000137	0.00316	CcSEcCtD
Sulindac—PTGS1—lymph node—Crohn's disease	0.000136	0.00495	CbGeAlD
Sulindac—Shock—Mesalazine—Crohn's disease	0.000135	0.00311	CcSEcCtD
Sulindac—Thrombocytopenia—Mesalazine—Crohn's disease	0.000134	0.00309	CcSEcCtD
Sulindac—Tachycardia—Mesalazine—Crohn's disease	0.000133	0.00308	CcSEcCtD
Sulindac—Hyperhidrosis—Mesalazine—Crohn's disease	0.000132	0.00305	CcSEcCtD
Sulindac—Anorexia—Mesalazine—Crohn's disease	0.00013	0.00301	CcSEcCtD
Sulindac—PTGS2—lymph node—Crohn's disease	0.00013	0.00473	CbGeAlD
Sulindac—Muscular weakness—Prednisone—Crohn's disease	0.00013	0.003	CcSEcCtD
Sulindac—Hypotension—Mesalazine—Crohn's disease	0.000128	0.00295	CcSEcCtD
Sulindac—Pancreatitis—Prednisone—Crohn's disease	0.000125	0.00288	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000125	0.00288	CcSEcCtD
Sulindac—Sweating increased—Prednisone—Crohn's disease	0.000124	0.00286	CcSEcCtD
Sulindac—Feeling abnormal—Azathioprine—Crohn's disease	0.000124	0.00286	CcSEcCtD
Sulindac—Insomnia—Mesalazine—Crohn's disease	0.000124	0.00286	CcSEcCtD
Sulindac—Paraesthesia—Mesalazine—Crohn's disease	0.000123	0.00283	CcSEcCtD
Sulindac—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000123	0.00283	CcSEcCtD
Sulindac—Dyspnoea—Mesalazine—Crohn's disease	0.000122	0.00281	CcSEcCtD
Sulindac—Somnolence—Mesalazine—Crohn's disease	0.000122	0.00281	CcSEcCtD
Sulindac—Dyspepsia—Mesalazine—Crohn's disease	0.00012	0.00278	CcSEcCtD
Sulindac—Neutropenia—Prednisone—Crohn's disease	0.000119	0.00275	CcSEcCtD
Sulindac—Decreased appetite—Mesalazine—Crohn's disease	0.000119	0.00274	CcSEcCtD
Sulindac—Body temperature increased—Azathioprine—Crohn's disease	0.000119	0.00274	CcSEcCtD
Sulindac—Fatigue—Mesalazine—Crohn's disease	0.000118	0.00272	CcSEcCtD
Sulindac—Constipation—Mesalazine—Crohn's disease	0.000117	0.0027	CcSEcCtD
Sulindac—Hyperglycaemia—Prednisone—Crohn's disease	0.000115	0.00265	CcSEcCtD
Sulindac—Depression—Prednisone—Crohn's disease	0.000113	0.00261	CcSEcCtD
Sulindac—Feeling abnormal—Mesalazine—Crohn's disease	0.000113	0.0026	CcSEcCtD
Sulindac—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000112	0.00258	CcSEcCtD
Sulindac—Neuropathy peripheral—Prednisone—Crohn's disease	0.000111	0.00257	CcSEcCtD
Sulindac—Hypersensitivity—Azathioprine—Crohn's disease	0.000111	0.00255	CcSEcCtD
Sulindac—Urticaria—Mesalazine—Crohn's disease	0.000109	0.00251	CcSEcCtD
Sulindac—Body temperature increased—Mesalazine—Crohn's disease	0.000108	0.0025	CcSEcCtD
Sulindac—Diarrhoea—Azathioprine—Crohn's disease	0.000103	0.00237	CcSEcCtD
Sulindac—Hypersensitivity—Mesalazine—Crohn's disease	0.000101	0.00233	CcSEcCtD
Sulindac—Dizziness—Azathioprine—Crohn's disease	9.93e-05	0.00229	CcSEcCtD
Sulindac—Asthenia—Mesalazine—Crohn's disease	9.81e-05	0.00226	CcSEcCtD
Sulindac—Pruritus—Mesalazine—Crohn's disease	9.67e-05	0.00223	CcSEcCtD
Sulindac—Vomiting—Azathioprine—Crohn's disease	9.54e-05	0.0022	CcSEcCtD
Sulindac—Rash—Azathioprine—Crohn's disease	9.46e-05	0.00219	CcSEcCtD
Sulindac—Dermatitis—Azathioprine—Crohn's disease	9.45e-05	0.00218	CcSEcCtD
Sulindac—Flushing—Prednisone—Crohn's disease	9.45e-05	0.00218	CcSEcCtD
Sulindac—Headache—Azathioprine—Crohn's disease	9.4e-05	0.00217	CcSEcCtD
Sulindac—Diarrhoea—Mesalazine—Crohn's disease	9.35e-05	0.00216	CcSEcCtD
Sulindac—Arrhythmia—Prednisone—Crohn's disease	9.1e-05	0.0021	CcSEcCtD
Sulindac—Dizziness—Mesalazine—Crohn's disease	9.04e-05	0.00209	CcSEcCtD
Sulindac—Alopecia—Prednisone—Crohn's disease	9e-05	0.00208	CcSEcCtD
Sulindac—Nausea—Azathioprine—Crohn's disease	8.92e-05	0.00206	CcSEcCtD
Sulindac—Vomiting—Mesalazine—Crohn's disease	8.69e-05	0.00201	CcSEcCtD
Sulindac—Rash—Mesalazine—Crohn's disease	8.62e-05	0.00199	CcSEcCtD
Sulindac—Dermatitis—Mesalazine—Crohn's disease	8.61e-05	0.00199	CcSEcCtD
Sulindac—Headache—Mesalazine—Crohn's disease	8.56e-05	0.00198	CcSEcCtD
Sulindac—Vision blurred—Prednisone—Crohn's disease	8.35e-05	0.00193	CcSEcCtD
Sulindac—Ill-defined disorder—Prednisone—Crohn's disease	8.22e-05	0.0019	CcSEcCtD
Sulindac—Anaemia—Prednisone—Crohn's disease	8.19e-05	0.00189	CcSEcCtD
Sulindac—Nausea—Mesalazine—Crohn's disease	8.12e-05	0.00188	CcSEcCtD
Sulindac—Angioedema—Prednisone—Crohn's disease	8.1e-05	0.00187	CcSEcCtD
Sulindac—Malaise—Prednisone—Crohn's disease	7.99e-05	0.00185	CcSEcCtD
Sulindac—Vertigo—Prednisone—Crohn's disease	7.96e-05	0.00184	CcSEcCtD
Sulindac—Syncope—Prednisone—Crohn's disease	7.95e-05	0.00184	CcSEcCtD
Sulindac—Loss of consciousness—Prednisone—Crohn's disease	7.79e-05	0.0018	CcSEcCtD
Sulindac—Convulsion—Prednisone—Crohn's disease	7.68e-05	0.00177	CcSEcCtD
Sulindac—Hypertension—Prednisone—Crohn's disease	7.65e-05	0.00177	CcSEcCtD
Sulindac—Arthralgia—Prednisone—Crohn's disease	7.55e-05	0.00174	CcSEcCtD
Sulindac—Myalgia—Prednisone—Crohn's disease	7.55e-05	0.00174	CcSEcCtD
Sulindac—Discomfort—Prednisone—Crohn's disease	7.46e-05	0.00172	CcSEcCtD
Sulindac—Anaphylactic shock—Prednisone—Crohn's disease	7.23e-05	0.00167	CcSEcCtD
Sulindac—Oedema—Prednisone—Crohn's disease	7.23e-05	0.00167	CcSEcCtD
Sulindac—Shock—Prednisone—Crohn's disease	7.12e-05	0.00164	CcSEcCtD
Sulindac—Tachycardia—Prednisone—Crohn's disease	7.06e-05	0.00163	CcSEcCtD
Sulindac—Hyperhidrosis—Prednisone—Crohn's disease	6.99e-05	0.00161	CcSEcCtD
Sulindac—Anorexia—Prednisone—Crohn's disease	6.9e-05	0.00159	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Prednisone—Crohn's disease	6.59e-05	0.00152	CcSEcCtD
Sulindac—Insomnia—Prednisone—Crohn's disease	6.54e-05	0.00151	CcSEcCtD
Sulindac—Paraesthesia—Prednisone—Crohn's disease	6.5e-05	0.0015	CcSEcCtD
Sulindac—Dyspepsia—Prednisone—Crohn's disease	6.37e-05	0.00147	CcSEcCtD
Sulindac—Decreased appetite—Prednisone—Crohn's disease	6.29e-05	0.00145	CcSEcCtD
Sulindac—Fatigue—Prednisone—Crohn's disease	6.24e-05	0.00144	CcSEcCtD
Sulindac—Constipation—Prednisone—Crohn's disease	6.19e-05	0.00143	CcSEcCtD
Sulindac—Feeling abnormal—Prednisone—Crohn's disease	5.96e-05	0.00138	CcSEcCtD
Sulindac—Gastrointestinal pain—Prednisone—Crohn's disease	5.92e-05	0.00137	CcSEcCtD
Sulindac—Urticaria—Prednisone—Crohn's disease	5.75e-05	0.00133	CcSEcCtD
Sulindac—Body temperature increased—Prednisone—Crohn's disease	5.72e-05	0.00132	CcSEcCtD
Sulindac—Hypersensitivity—Prednisone—Crohn's disease	5.33e-05	0.00123	CcSEcCtD
Sulindac—Asthenia—Prednisone—Crohn's disease	5.19e-05	0.0012	CcSEcCtD
Sulindac—Pruritus—Prednisone—Crohn's disease	5.12e-05	0.00118	CcSEcCtD
Sulindac—Diarrhoea—Prednisone—Crohn's disease	4.95e-05	0.00114	CcSEcCtD
Sulindac—Dizziness—Prednisone—Crohn's disease	4.78e-05	0.0011	CcSEcCtD
Sulindac—Vomiting—Prednisone—Crohn's disease	4.6e-05	0.00106	CcSEcCtD
Sulindac—Rash—Prednisone—Crohn's disease	4.56e-05	0.00105	CcSEcCtD
Sulindac—Dermatitis—Prednisone—Crohn's disease	4.56e-05	0.00105	CcSEcCtD
Sulindac—Headache—Prednisone—Crohn's disease	4.53e-05	0.00105	CcSEcCtD
Sulindac—Nausea—Prednisone—Crohn's disease	4.3e-05	0.000992	CcSEcCtD
Sulindac—ALB—Platelet activation, signaling and aggregation—RASGRP1—Crohn's disease	2.24e-05	0.000321	CbGpPWpGaD
Sulindac—ALB—Vitamin B12 Metabolism—TNF—Crohn's disease	2.24e-05	0.00032	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—IFNG—Crohn's disease	2.24e-05	0.00032	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TAGAP—Crohn's disease	2.23e-05	0.00032	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—SMAD3—Crohn's disease	2.22e-05	0.000317	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.21e-05	0.000317	CbGpPWpGaD
Sulindac—MAPK3—MyD88-independent cascade—IL6—Crohn's disease	2.21e-05	0.000316	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—IFNG—Crohn's disease	2.19e-05	0.000313	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—RASGRP1—Crohn's disease	2.16e-05	0.000309	CbGpPWpGaD
Sulindac—MAPK3—Toll-like Receptor Signaling Pathway—IL6—Crohn's disease	2.16e-05	0.000309	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—PTGS2—Crohn's disease	2.14e-05	0.000307	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—STAT3—Crohn's disease	2.14e-05	0.000307	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—CXCL8—Crohn's disease	2.13e-05	0.000305	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—TAB1—Crohn's disease	2.11e-05	0.000303	CbGpPWpGaD
Sulindac—MAPK3—Senescence-Associated Secretory Phenotype (SASP)—IL6—Crohn's disease	2.11e-05	0.000302	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.1e-05	0.0003	CbGpPWpGaD
Sulindac—MAPK3—Regulation of toll-like receptor signaling pathway—TNF—Crohn's disease	2.09e-05	0.000299	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—NOD2—Crohn's disease	2.08e-05	0.000297	CbGpPWpGaD
Sulindac—MAPK3—VEGFA-VEGFR2 Pathway—IL6—Crohn's disease	2.08e-05	0.000297	CbGpPWpGaD
Sulindac—MAPK3—Signaling by Interleukins—IL6—Crohn's disease	2.06e-05	0.000295	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—IL2RA—Crohn's disease	2.05e-05	0.000294	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—CXCL8—Crohn's disease	2.03e-05	0.000291	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.02e-05	0.000289	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PLA2G4F—Crohn's disease	2e-05	0.000286	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—IL1B—Crohn's disease	1.99e-05	0.000285	CbGpPWpGaD
Sulindac—ALB—Hemostasis—F5—Crohn's disease	1.99e-05	0.000285	CbGpPWpGaD
Sulindac—MAPK3—Activated TLR4 signalling—IL6—Crohn's disease	1.99e-05	0.000284	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—STAT3—Crohn's disease	1.99e-05	0.000284	CbGpPWpGaD
Sulindac—SLC22A6—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.98e-05	0.000284	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—TYK2—Crohn's disease	1.97e-05	0.000281	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.96e-05	0.000281	CbGpPWpGaD
Sulindac—PPARD—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.96e-05	0.000281	CbGpPWpGaD
Sulindac—MAPK3—Signaling by VEGF—IL6—Crohn's disease	1.96e-05	0.00028	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—SOCS1—Crohn's disease	1.96e-05	0.00028	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—RSPO3—Crohn's disease	1.95e-05	0.00028	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—IL1B—Crohn's disease	1.95e-05	0.000279	CbGpPWpGaD
Sulindac—MAPK3—Signaling by Insulin receptor—IL6—Crohn's disease	1.95e-05	0.000279	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—STAT3—Crohn's disease	1.94e-05	0.000278	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—TYK2—Crohn's disease	1.93e-05	0.000277	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—IL6—Crohn's disease	1.92e-05	0.000275	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—SMAD3—Crohn's disease	1.92e-05	0.000274	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—SMAD3—Crohn's disease	1.91e-05	0.000274	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.91e-05	0.000274	CbGpPWpGaD
Sulindac—MAPK3—Disease—GCKR—Crohn's disease	1.91e-05	0.000274	CbGpPWpGaD
Sulindac—MAPK3—Immune System—NOD1—Crohn's disease	1.91e-05	0.000273	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—STAT3—Crohn's disease	1.91e-05	0.000273	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CCR6—Crohn's disease	1.9e-05	0.000272	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—JAK2—Crohn's disease	1.88e-05	0.000268	CbGpPWpGaD
Sulindac—MAPK3—Toll Like Receptor 4 (TLR4) Cascade—IL6—Crohn's disease	1.87e-05	0.000267	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SEL1L—Crohn's disease	1.85e-05	0.000265	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—JAK2—Crohn's disease	1.84e-05	0.000264	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—IFNG—Crohn's disease	1.84e-05	0.000263	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—TNF—Crohn's disease	1.82e-05	0.000261	CbGpPWpGaD
Sulindac—PTGS1—Selenium Micronutrient Network—IL6—Crohn's disease	1.82e-05	0.00026	CbGpPWpGaD
Sulindac—ALB—Vitamin B12 Metabolism—IL6—Crohn's disease	1.81e-05	0.000259	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—CXCL8—Crohn's disease	1.79e-05	0.000257	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—TNF—Crohn's disease	1.79e-05	0.000257	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.79e-05	0.000256	CbGpPWpGaD
Sulindac—PTGS2—Selenium Micronutrient Network—TNF—Crohn's disease	1.79e-05	0.000256	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—STAT3—Crohn's disease	1.76e-05	0.000252	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—TYK2—Crohn's disease	1.75e-05	0.00025	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—IL2RA—Crohn's disease	1.74e-05	0.000249	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CCR6—Crohn's disease	1.74e-05	0.000248	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.72e-05	0.000246	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—MTMR3—Crohn's disease	1.7e-05	0.000244	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	1.7e-05	0.000243	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	1.7e-05	0.000243	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCR9—Crohn's disease	1.69e-05	0.000242	CbGpPWpGaD
Sulindac—MAPK3—Disease—SLC11A1—Crohn's disease	1.69e-05	0.000242	CbGpPWpGaD
Sulindac—MAPK3—Regulation of toll-like receptor signaling pathway—IL6—Crohn's disease	1.68e-05	0.000241	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—PTGER4—Crohn's disease	1.67e-05	0.000239	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—JAK2—Crohn's disease	1.67e-05	0.000239	CbGpPWpGaD
Sulindac—MAPK3—Toll-Like Receptors Cascades—IL6—Crohn's disease	1.67e-05	0.000238	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—IL6—Crohn's disease	1.67e-05	0.000238	CbGpPWpGaD
Sulindac—PTGS2—Disease—RSPO3—Crohn's disease	1.66e-05	0.000237	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—GCKR—Crohn's disease	1.64e-05	0.000235	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—IL1B—Crohn's disease	1.64e-05	0.000235	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	1.62e-05	0.000232	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	1.62e-05	0.000232	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—IL6—Crohn's disease	1.59e-05	0.000228	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PLA2G4F—Crohn's disease	1.59e-05	0.000227	CbGpPWpGaD
Sulindac—MAPK3—Immune System—PTPN2—Crohn's disease	1.59e-05	0.000227	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—GPR65—Crohn's disease	1.57e-05	0.000225	CbGpPWpGaD
Sulindac—PTGS2—Disease—SEL1L—Crohn's disease	1.57e-05	0.000225	CbGpPWpGaD
Sulindac—MAPK3—Immune System—RBX1—Crohn's disease	1.57e-05	0.000225	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—IL6—Crohn's disease	1.57e-05	0.000224	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—HSPA1B—Crohn's disease	1.56e-05	0.000223	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—IL6—Crohn's disease	1.5e-05	0.000214	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—IL6—Crohn's disease	1.49e-05	0.000213	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—IL6—Crohn's disease	1.48e-05	0.000212	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—CRP—Crohn's disease	1.48e-05	0.000211	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—IL6—Crohn's disease	1.48e-05	0.000211	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—IL6—Crohn's disease	1.47e-05	0.00021	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	1.45e-05	0.000208	CbGpPWpGaD
Sulindac—MAPK3—Disease—RBX1—Crohn's disease	1.45e-05	0.000207	CbGpPWpGaD
Sulindac—MAPK3—Disease—HSPA1B—Crohn's disease	1.45e-05	0.000207	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—TNF—Crohn's disease	1.45e-05	0.000207	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TYK2—Crohn's disease	1.45e-05	0.000207	CbGpPWpGaD
Sulindac—PTGS2—Selenium Micronutrient Network—IL6—Crohn's disease	1.44e-05	0.000207	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—STAT3—Crohn's disease	1.44e-05	0.000207	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL3—Crohn's disease	1.42e-05	0.000204	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—TLR4—Crohn's disease	1.42e-05	0.000203	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—TNF—Crohn's disease	1.41e-05	0.000202	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PLA2G4F—Crohn's disease	1.41e-05	0.000202	CbGpPWpGaD
Sulindac—PTGS2—Disease—LTF—Crohn's disease	1.41e-05	0.000202	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—IL6—Crohn's disease	1.39e-05	0.000199	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—IL6—Crohn's disease	1.39e-05	0.000199	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—IL6—Crohn's disease	1.39e-05	0.000199	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—JAK2—Crohn's disease	1.38e-05	0.000198	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—RASGRP1—Crohn's disease	1.38e-05	0.000197	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—STAT3—Crohn's disease	1.38e-05	0.000197	CbGpPWpGaD
Sulindac—MAPK3—Immune System—UBE2D1—Crohn's disease	1.38e-05	0.000197	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—IL6—Crohn's disease	1.38e-05	0.000197	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—UBE2D1—Crohn's disease	1.37e-05	0.000196	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—IL6—Crohn's disease	1.36e-05	0.000195	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—IL6—Crohn's disease	1.36e-05	0.000194	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—STAT3—Crohn's disease	1.35e-05	0.000194	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—MTMR3—Crohn's disease	1.35e-05	0.000193	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.34e-05	0.000191	CbGpPWpGaD
Sulindac—MAPK3—Immune System—RIPK2—Crohn's disease	1.33e-05	0.000191	CbGpPWpGaD
Sulindac—MAPK3—Immune System—ITGA4—Crohn's disease	1.33e-05	0.000191	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—IL6—Crohn's disease	1.33e-05	0.000191	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—FADS1—Crohn's disease	1.33e-05	0.00019	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL3—Crohn's disease	1.3e-05	0.000186	CbGpPWpGaD
Sulindac—ALB—Metabolism—PLA2G4F—Crohn's disease	1.29e-05	0.000184	CbGpPWpGaD
Sulindac—MAPK3—Disease—UBE2D1—Crohn's disease	1.27e-05	0.000182	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—CXCL8—Crohn's disease	1.26e-05	0.00018	CbGpPWpGaD
Sulindac—MAPK3—Immune System—RASGRP1—Crohn's disease	1.26e-05	0.00018	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—ALB—Crohn's disease	1.26e-05	0.00018	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD79A—Crohn's disease	1.25e-05	0.00018	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.25e-05	0.000179	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—TYK2—Crohn's disease	1.25e-05	0.000179	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—GPX4—Crohn's disease	1.24e-05	0.000178	CbGpPWpGaD
Sulindac—MAPK3—Immune System—TAB1—Crohn's disease	1.23e-05	0.000176	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—IL6—Crohn's disease	1.23e-05	0.000176	CbGpPWpGaD
Sulindac—ALB—Hemostasis—ITGA4—Crohn's disease	1.22e-05	0.000175	CbGpPWpGaD
Sulindac—MAPK3—Immune System—NOD2—Crohn's disease	1.21e-05	0.000173	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—MTMR3—Crohn's disease	1.2e-05	0.000172	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—GCKR—Crohn's disease	1.2e-05	0.000172	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—IL6—Crohn's disease	1.2e-05	0.000171	CbGpPWpGaD
Sulindac—ALB—Hemostasis—IL3—Crohn's disease	1.19e-05	0.000171	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—JAK2—Crohn's disease	1.19e-05	0.00017	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	1.19e-05	0.00017	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—JAK2—Crohn's disease	1.17e-05	0.000167	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—IL6—Crohn's disease	1.17e-05	0.000167	CbGpPWpGaD
Sulindac—ALB—Hemostasis—RASGRP1—Crohn's disease	1.15e-05	0.000165	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—IL6—Crohn's disease	1.14e-05	0.000163	CbGpPWpGaD
Sulindac—MAPK3—Immune System—SOCS1—Crohn's disease	1.14e-05	0.000163	CbGpPWpGaD
Sulindac—PTGS2—Disease—GCKR—Crohn's disease	1.14e-05	0.000163	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCR6—Crohn's disease	1.12e-05	0.000161	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—TYK2—Crohn's disease	1.1e-05	0.000158	CbGpPWpGaD
Sulindac—ALB—Metabolism—MTMR3—Crohn's disease	1.09e-05	0.000156	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	1.09e-05	0.000156	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—FADS1—Crohn's disease	1.05e-05	0.000151	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—JAK2—Crohn's disease	1.05e-05	0.000151	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL18—Crohn's disease	1.03e-05	0.000147	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—RBX1—Crohn's disease	1.01e-05	0.000145	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—STAT3—Crohn's disease	1.01e-05	0.000145	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—IL6—Crohn's disease	1.01e-05	0.000144	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—ALB—Crohn's disease	1.01e-05	0.000144	CbGpPWpGaD
Sulindac—PTGS2—Disease—SLC11A1—Crohn's disease	1.01e-05	0.000144	CbGpPWpGaD
Sulindac—PPARD—Metabolism—ALB—Crohn's disease	9.98e-06	0.000143	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL2RA—Crohn's disease	9.98e-06	0.000143	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—CD4—Crohn's disease	9.97e-06	0.000143	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PTGER4—Crohn's disease	9.88e-06	0.000141	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GPX4—Crohn's disease	9.86e-06	0.000141	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—SMAD3—Crohn's disease	9.79e-06	0.00014	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	9.63e-06	0.000138	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—IL6—Crohn's disease	9.62e-06	0.000138	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GCKR—Crohn's disease	9.52e-06	0.000136	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—IL6—Crohn's disease	9.46e-06	0.000135	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—FADS1—Crohn's disease	9.35e-06	0.000134	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL2RA—Crohn's disease	9.12e-06	0.00013	CbGpPWpGaD
Sulindac—MAPK3—Disease—SMAD3—Crohn's disease	9.09e-06	0.00013	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	9e-06	0.000129	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—UBE2D1—Crohn's disease	8.9e-06	0.000127	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GPX4—Crohn's disease	8.75e-06	0.000125	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—STAT3—Crohn's disease	8.74e-06	0.000125	CbGpPWpGaD
Sulindac—PPARD—Metabolism—PTGS2—Crohn's disease	8.73e-06	0.000125	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—RIPK2—Crohn's disease	8.63e-06	0.000123	CbGpPWpGaD
Sulindac—PTGS2—Disease—RBX1—Crohn's disease	8.62e-06	0.000123	CbGpPWpGaD
Sulindac—PTGS2—Disease—HSPA1B—Crohn's disease	8.62e-06	0.000123	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CRP—Crohn's disease	8.6e-06	0.000123	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	8.57e-06	0.000123	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—IL6—Crohn's disease	8.56e-06	0.000122	CbGpPWpGaD
Sulindac—ALB—Metabolism—FADS1—Crohn's disease	8.52e-06	0.000122	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GCKR—Crohn's disease	8.45e-06	0.000121	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL3—Crohn's disease	8.41e-06	0.00012	CbGpPWpGaD
Sulindac—ALB—Hemostasis—IL2RA—Crohn's disease	8.36e-06	0.00012	CbGpPWpGaD
Sulindac—MAPK3—Immune System—TLR4—Crohn's disease	8.24e-06	0.000118	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—RASGRP1—Crohn's disease	8.14e-06	0.000116	CbGpPWpGaD
Sulindac—ALB—Metabolism—GPX4—Crohn's disease	7.98e-06	0.000114	CbGpPWpGaD
Sulindac—MAPK3—Immune System—ICAM1—Crohn's disease	7.9e-06	0.000113	CbGpPWpGaD
Sulindac—ALB—Metabolism—GCKR—Crohn's disease	7.7e-06	0.00011	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—MTMR3—Crohn's disease	7.65e-06	0.000109	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—TNF—Crohn's disease	7.57e-06	0.000108	CbGpPWpGaD
Sulindac—PTGS2—Disease—UBE2D1—Crohn's disease	7.56e-06	0.000108	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	7.5e-06	0.000107	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SOCS1—Crohn's disease	7.37e-06	0.000105	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—IL6—Crohn's disease	7.08e-06	0.000101	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—TYK2—Crohn's disease	7.03e-06	0.000101	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	6.81e-06	9.74e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—JAK2—Crohn's disease	6.71e-06	9.6e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—TYK2—Crohn's disease	6.42e-06	9.19e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SMAD3—Crohn's disease	6.37e-06	9.11e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—JAK2—Crohn's disease	6.13e-06	8.77e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CXCL8—Crohn's disease	6.12e-06	8.76e-05	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—IL6—Crohn's disease	6.11e-06	8.74e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	6.04e-06	8.64e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IFNG—Crohn's disease	6.01e-06	8.61e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—FADS1—Crohn's disease	5.96e-06	8.53e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—TYK2—Crohn's disease	5.93e-06	8.48e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL2RA—Crohn's disease	5.89e-06	8.43e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD4—Crohn's disease	5.81e-06	8.31e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—JAK2—Crohn's disease	5.66e-06	8.09e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—JAK2—Crohn's disease	5.62e-06	8.04e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GPX4—Crohn's disease	5.58e-06	7.98e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—SMAD3—Crohn's disease	5.41e-06	7.73e-05	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—IL6—Crohn's disease	5.39e-06	7.72e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GCKR—Crohn's disease	5.39e-06	7.71e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL1B—Crohn's disease	5.36e-06	7.68e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—CD4—Crohn's disease	5.36e-06	7.67e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—PTGS2—Crohn's disease	5.32e-06	7.62e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	5.28e-06	7.56e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.82e-06	6.89e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—STAT3—Crohn's disease	4.5e-06	6.43e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TYK2—Crohn's disease	4.15e-06	5.94e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—STAT3—Crohn's disease	4.15e-06	5.94e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—JAK2—Crohn's disease	3.96e-06	5.67e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.85e-06	5.51e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ALB—Crohn's disease	3.82e-06	5.46e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CXCL8—Crohn's disease	3.62e-06	5.17e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—TYK2—Crohn's disease	3.53e-06	5.05e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL6—Crohn's disease	3.44e-06	4.92e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.37e-06	4.82e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—JAK2—Crohn's disease	3.36e-06	4.81e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PTGS2—Crohn's disease	3.34e-06	4.78e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CD4—Crohn's disease	3.19e-06	4.56e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL6—Crohn's disease	3.14e-06	4.49e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ALB—Crohn's disease	3.03e-06	4.34e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—STAT3—Crohn's disease	2.91e-06	4.16e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—IL6—Crohn's disease	2.9e-06	4.15e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ALB—Crohn's disease	2.69e-06	3.85e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—STAT3—Crohn's disease	2.47e-06	3.53e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PTGS2—Crohn's disease	2.35e-06	3.37e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PTGS2—Crohn's disease	2.15e-06	3.07e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL6—Crohn's disease	2.03e-06	2.91e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—IL6—Crohn's disease	1.72e-06	2.47e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ALB—Crohn's disease	1.72e-06	2.45e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PTGS2—Crohn's disease	1.5e-06	2.15e-05	CbGpPWpGaD
